Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1425 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting UltraShape Device for Non-Invasive Fat Reduction in the Male Breast (Pseudogynecomastia)
Conditions: Gynecomastia;   Male Breast Enlargement
Intervention: Device: UltraShape focused ultrasound device
22 Recruiting Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
Condition: Breast Cancer
Interventions: Device: Focused Microwave Thermotherapy;   Drug: Chemotherapy (control)
23 Not yet recruiting G1T28 (CDK 4/6 Inhibitor) in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
Conditions: Triple-Negative Breast Neoplasms;   Breast Neoplasm;   Breast Cancer;   Triple-Negative Breast Cancer
Interventions: Drug: G1T28;   Drug: Gemcitabine;   Drug: Carboplatin
24 Not yet recruiting A Study of Anti-PD-1 (Pembrolizumab) + Hormonal Therapy in HR-positive Localized IBC Patients With Non-pCR to Neoadjuvant Chemotherapy
Conditions: Inflammatory Breast Cancer;   Malignant Neoplasm of Breast
Intervention: Drug: Pembrolizumab
25 Not yet recruiting Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Conditions: Breast Neoplasm;   Breast Neoplasm, Male
Interventions: Drug: Cyclophosphamide;   Drug: Indomethacin;   Drug: Omeprazole;   Dietary Supplement: Multivitamin
26 Recruiting Effectiveness of Nefopam in Breast Cancer Surgery
Condition: Breast Neoplasm Malignant Primary
Interventions: Drug: Nefopam;   Drug: Normal Saline
27 Not yet recruiting Shortening Adjuvant Photon Irradiation to Reduce Edema (SAPHIRE): Hypofractionated Versus Conventionally Fractionated Regional Nodal Irradiation for Invasive Breast Cancer
Condition: Malignant Neoplasm of Breast
Interventions: Radiation: Radiation Therapy;   Behavioral: Questionnaires
28 Not yet recruiting Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Chemotherapy
Conditions: Breast Cancer;   Breast Tumors;   Cancer of Breast;   Cancer of the Breast;   Malignant Neoplasm of Breast
Intervention: Device: Optical Tomography Using Near Infrared Diffused Light Assisted with Ultrasound
29 Recruiting A Phase II Study of Using Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen (AC) for New Triple-Negative Inflammatory Breast Cancer (TN-IBC)
Condition: Malignant Neoplasm of Breast
Interventions: Procedure: Breast Core Biopsy;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Panitumumab;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Procedure: Mammogram;   Procedure: Ultrasound;   Other: Follow Up
30 Recruiting Acupuncture for Post-Mastectomy Pain Syndrome (PMPS)
Condition: Malignant Neoplasm of Breast
Interventions: Procedure: Electro-Acupuncture;   Procedure: Sham Electro-Acupuncture;   Other: Standard of Care;   Behavioral: Questionnaires
31 Recruiting Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
Conditions: Breast Cancer;   Malignant Neoplasm of Breast
Interventions: Procedure: Dynamic Contrast Enhanced Molecular Resonance Imaging (DCE-MRI);   Procedure: Tc99m Sestamibi Molecular Breast Imaging (MBI);   Drug: 99mTc Sestamibi
32 Recruiting Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Conditions: Breast Neoplasms;   Triple Negative Breast Neoplasms
Interventions: Drug: Dasatinib;   Procedure: Conventional Surgery;   Other: Laboratory Biomarker Analysis
33 Not yet recruiting A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Neoplasms;   Triple-Negative Breast Neoplasm;   Triple-Negative Breast Cancer;   Triple Negative Breast Cancer;   ER-Negative PR-Negative HER2-Negative Breast Neoplasms;   ER-Negative PR-Negative HER2-Negative Breast Cancer
Interventions: Biological: Bavituximab;   Drug: Taxane
34 Recruiting Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Estrogen Receptor Positive Breast Cancer;   Progesterone Receptor Positive Tumor;   Metastatic Breast Cancer
Interventions: Drug: Palbociclib;   Drug: Tamoxifen
35 Recruiting Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery Patients
Condition: Malignant Neoplasm of Breast
Interventions: Procedure: PECS Block;   Drug: Bupivacaine 0.25-0.5%
36 Recruiting Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer
Conditions: Breast Cancer;   Ovarian Cancer;   Advanced Cancer
Intervention: Drug: carboplatin, olaparib
37 Recruiting MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery
Condition: Malignant Neoplasm of Breast
Interventions: Drug: Saline;   Drug: Ropivacaine
38 Recruiting Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer;   Breast Cancer;   Hormone Receptor Positive Tumor;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Locally Advanced Malignant Neoplasm
Interventions: Drug: Everolimus;   Drug: Exemestane;   Drug: Fulvestrant
39 Recruiting The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Intervention: Other: Questionnaires, Oncotype Dx Assay
40 Recruiting Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Conditions: Breast Cancer Recurrent;   HER2/Neu-negative Carcinoma of Breast;   Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Bevacizumab;   Drug: Capecitabine;   Drug: Everolimus;   Drug: Exemestane;   Other: Patient questionaires

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.